The "Acute Heart Failure (AHF) Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets.
This report analyzes the worldwide markets for Next Generation Sequencers in US$ Thousand.
The Global market is additionally analyzed by the following End-Use Segments:
The report profiles 93 companies including many key and niche players such as:
Key Topics Covered
1. Industry Overview
2. Market Drivers, Trends & Issues
3. Treatment of Acute Heart Failure (AHF)
4. Acute Heart Failure
5. Recent Industry Activity
6. Focus on Select Players
7. Global Market Perspective
Total Companies Profiled: 34 (including Divisions/Subsidiaries 35)
For more information about this report visit https://www.researchandmarkets.com/research/j95wwt/global_acute?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20180711005741/en/